Up close and personal: personalized medicine
How tailored can personalized medicine become?
Dr. Josep Prous from Thomson Reuters is quoted in a feature article in the March edition of PharmaTimes magazine. The article entitled - Up Close and Personal - looks at the booming market in personalized medicine, reportedly worth USD232 billion in the US, and asks the question: "Can tailored drugs solve healthcare’s problems?"
Dr Prous, chief scientific officer of Thomson Reuters, raises the million dollar question: how tailored can personalized medicine become, and still remain economically feasible for both drug development and healthcare provision?
The article is available free to download from the PharmaTimes website until the end of May.
Up close and personal: download the article (until end of May 2010)
Additional information
Up close and personal: download the article (until end of May 2010)